The Opportunity to Upgrade Pharyngitis Testing
Pharyngitis testing and diagnosis can be improved by utilizing existing molecular testing capacity increased due to COVID.
Pharyngitis testing and diagnosis can be improved by utilizing existing molecular testing capacity increased due to COVID.
Cue Health has announced that it submitted an application with the FDA for EUA for its Cue Flu + COVID-19 Molecular Test.
Applied BioCode has released 28 Fungal Analyte-Specific Reagents for use in molecular tests, which utilize the company’s BMB technology.
Thermo Fisher Scientific received EUA from the FDA to run COVID-19 tests from saliva samples collected with the SpectrumDNA SDNA-1000.
Read MoreAn AI-based technology rapidly diagnoses rare disorders in critically ill children with high accuracy, foreshadowing the next phase of medicine.
Read MoreSeegene is unveiling a fully automated PCR testing system this week at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo in Atlanta.
Read MorePerkinElmer, Inc. has announced its collaboration with the Mount Sinai Health System to increase accessibility of SARS-CoV-2 testing in New York City.
Read MoreA new sensor can detect not only whether a virus is present, but if it’s infectious – an important distinction for containing viral spread.
Read MoreMission Bio has announced two key improvements to the core capabilities of its Tapestri Platform for hematologic oncology (heme-onc) research.
Read MoreThe GENFLEX Molecular System is a high-throughput, automated, and scalable instrument for processing SARS-CoV-2 molecular diagnostic tests.
Read MoreDroplet digital PCR can detect covid-19 cases qPCR misses.
Read MoreWastewater testing—a strategy that has been used for decades by epidemiologists to track disease outbreaks—is being used to predict and stem the spread of SARS-CoV-2.
Read MoreThe September 2019 Tech Guide features molecular diagnostic systems and panels from Abbott Molecular, Agena bioscience, BD, Bio-Rad Laboratories, Luminex, NewMoDx, Qiagen, and more.
Read MoreThe CFX Opus 96 and CFX Opus 384 Real-Time PCR Systems represent the next generation of Bio-Rad’s CFX Real-Time PCR Systems that are used in research and genomic testing as well as in pathogen detection and infectious disease testing.
Read MoreGelato combines gel electrophoresis and transillumination technology for simultaneous nucleic acid separation and visualization in a single, compact system.
Read MoreIdylla reduced the average turnaround time for test results by more than 50% from 15 days to 5 days, with some results available in a single day.
Read More